These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2405920)

  • 21. Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia.
    Kantarjian HM; Smith T; Estey E; Polyzos A; O'Brien S; Pierce S; Beran M; Feldman E; Keating MJ
    Am J Med; 1992 Dec; 93(6):599-604. PubMed ID: 1466355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders.
    Garewal H; Durie BG; Kyle RA; Finley P; Bower B; Serokman R
    J Clin Oncol; 1984 Jan; 2(1):51-7. PubMed ID: 6366146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?
    van Dobbenburgh OA; Rodenhuis S; Ockhuizen T; Weltevreden E; Houwen B; Fidler V; Meijer S; Marrink J
    Br J Haematol; 1985 Dec; 61(4):611-20. PubMed ID: 3910076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum beta2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging.
    Bataille R; Durie BG; Grenier J
    Br J Haematol; 1983 Nov; 55(3):439-47. PubMed ID: 6357266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The significance of lactate dehydrogenase and beta 2-microglobulin levels for the assessment of the prognosis and choice of therapy in multiple myeloma].
    Iakovleva SV; Andreeva NE; Izgorodin AS
    Ter Arkh; 1995; 67(7):35-9. PubMed ID: 7482303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term prognostic value of serum beta 2 microglobulin in myelomatosis.
    Cuzick J; De Stavola BL; Cooper EH; Chapman C; MacLennan IC
    Br J Haematol; 1990 Aug; 75(4):506-10. PubMed ID: 2119793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group.
    Pelliniemi TT; Irjala K; Mattila K; Pulkki K; Rajamäki A; Tienhaara A; Laakso M; Lahtinen R
    Blood; 1995 Feb; 85(3):765-71. PubMed ID: 7530507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma.
    Witzig TE; Gertz MA; Lust JA; Kyle RA; O'Fallon WM; Greipp PR
    Blood; 1996 Sep; 88(5):1780-7. PubMed ID: 8781435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic correlation of plasma cell acid phosphatase and beta-glucuronidase in multiple myeloma: a Southwest Oncology Group study.
    Saeed SM; Stock-Novack D; Pohlod R; Crowley J; Salmon SE
    Blood; 1991 Dec; 78(12):3281-7. PubMed ID: 1742488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of relapsed/refractory multiple myeloma with thalidomide-based regimens: identification of prognostic factors.
    Anagnostopoulos A; Gika D; Hamilos G; Zervas K; Zomas A; Pouli A; Zorzou M; Kastritis E; Anagnostopoulos N; Tassidou A; Anagnostou D; Dimopoulos MA
    Leuk Lymphoma; 2004 Nov; 45(11):2275-9. PubMed ID: 15512817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis.
    Cuzick J; Cooper EH; MacLennan IC
    Br J Cancer; 1985 Jul; 52(1):1-6. PubMed ID: 3893505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma.
    Greipp PR; Lust JA; O'Fallon WM; Katzmann JA; Witzig TE; Kyle RA
    Blood; 1993 Jun; 81(12):3382-7. PubMed ID: 8507875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of serum beta 2-microglobulin and 24 hour urinary creatinine clearance as a prognostic factor in multiple myeloma.
    Yun JP; Suh C; Lee E; Chang JW; Yang WS; Park JS; Park SK
    J Korean Med Sci; 2006 Aug; 21(4):639-44. PubMed ID: 16891806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of myeloma cells by means of labeling index, bone marrow histology, and serum beta 2-microglobulin.
    Schambeck CM; Bartl R; Höchtlen-Vollmar W; Wick M; Lamerz R; Fateh-Moghadam A
    Am J Clin Pathol; 1996 Jul; 106(1):64-8. PubMed ID: 8701935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognositic factors in multiple myeloma].
    Nagura E
    Nihon Rinsho; 2007 Dec; 65(12):2351-6. PubMed ID: 18069282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosis.
    Child JA; Crawford SM; Norfolk DR; O'Quigley J; Scarffe JH; Struthers LP
    Br J Cancer; 1983 Jan; 47(1):111-4. PubMed ID: 6185132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of correction of serum beta 2-microglobulin levels for serum creatinine in multiple myeloma.
    Scudla V; Vavrdová V; Budíková M; Indrák K
    Acta Univ Palacki Olomuc Fac Med; 1991; 131():257-64. PubMed ID: 1840347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).
    Abildgaard N; Bentzen SM; Nielsen JL; Heickendorff L
    Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].
    Tao ZF; Fu WJ; Chen YB; Yuan ZG; Wang DX; Hou J
    Ai Zheng; 2006 Apr; 25(4):461-4. PubMed ID: 16613681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New prognostic factors in multiple myeloma.
    Bettini R; Rapazzini P; Marrapodi E
    Haematologica; 1987; 72(1):102-3. PubMed ID: 3108088
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.